|
Adult pneumococcal polysaccharide
|
Adult pneumococcal polysaccharide
|
Adult pneumococcal polysaccharide
|
|
Diphtheria, pertussis, tetanus, and components
|
Diphtheria, tetanus, acellular pertussis, and components b
|
DTaPc
|
|
Measles, mumps, and rubella
|
MMRb
|
Measles, mumps, rubella, and varicellac
|
|
Oral poliovirus
|
Inactivated poliovirusb
H. influenzae type bb
Hepatitis Ab
Hepatitis Bb
Varicellab
Pediatric conjugate of pneumococcal polysaccharide
Borrelia burgdorferi
Meningococcal polysaccharide A,C,Y,W-135
|
Eradication of polio expected
Hibc
Hepatitis Ac
Hepatitis Bc
Varicella with MMR
Pediatric conjugate of pneumococcal polysaccharidec
Borrelia burgdorferi
Conjugated meningococcal polysaccharide A,B,C,Y,W-135c
Adult tetanus, diphtheria, acellular pertussis, and componentsc
Chlamydia
Coccidioides immites
Cytomegalovirus
Enterotoxigenic E.coli
Epstein-Barr
Helicobacter pyloric
Hepatitis Cc
Herpes simplex
Histoplasma capsulatum
Human papillomavirusc
Child influenzac
Insulin-dependent diabetes mellitus (therapeutic)
Melanoma (therapeutic)
Multiple sclerosis (therapeutic)
Mycobacterium tuberculosis
Neisseria gonorrhea
Neisseria meningitidis B
Parainfluenzac
Respiratory syncytial virusc
Rheumatoid arthritis (therapeutic)
Rotavirusc
Shigella
Streptococcus, Group Ac
Streptococcus, Group B
|
|
aPriority candidate vaccines, drawn from IOM, 1999b.
bVaccines covered by Vaccines for Children (VFC) as of February 2000.
cVaccines likely to be recommended for universal use (including VFC coverage for childhood vaccines).
|
